Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Jan 2021

Gyawali Bishal, West Howard Jack

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acrylamides
Share to Aniline Compounds
Share to Chemotherapy, Adjuvant
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Costs

Share to Evidence-Based Medicine

Share to Progression-Free Survival

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 33275490
DOI: 10.1200/JCO.20.01762

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics.PMID 33275490Read ↗

Lessons from ADAURA: Can we improve on a positive trial?Semantic proximity Read ↗

Cancer clinical trials : identifying & testing approaches to impact evaluationSemantic proximity Read ↗

Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible DocumentationSemantic proximity Read ↗

Quantifying the Dual Value and Governance Risks of Early Access Programs in Oncology: A Single-Centre Analysis and National Policy FrameworkSemantic proximity Read ↗

Comparison of Clinical Evidence Submitted to the FDA and EMA for Cell and Gene TherapiesSemantic proximity Read ↗

Mapping the Landscape of Financial Toxicity Assessment in Cancer: A Scoping ReviewSemantic proximity Read ↗

Benefit-Risk Assessment of Medical Products Using Bayesian Multi-Criteria Augmented Decision Analysis for Clinical DevelopmentSemantic proximity Read ↗

Adaptive health technology assessments to inform oncology based priority setting in IndiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.